Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/1995
12/21/1995WO1995034315A1 Radiolabeled annexin-galactose conjugates
12/21/1995WO1995034313A1 Methods for treating cancer and other cell proliferative diseases
12/21/1995WO1995034312A1 Constrained peptides
12/21/1995WO1995034311A1 Piperazine compounds promote release of growth hormone
12/21/1995WO1995034307A1 Ceramide-activated protein kinase and methods of use of effectors
12/21/1995WO1995034306A1 Use of immunosuppressive agents for the treatment of schizophrenia
12/21/1995WO1995034295A1 A novel method for importing biologically active molecules into cells
12/21/1995WO1995034289A1 Compositions for neutralization of lipopolysaccharides
12/21/1995WO1995034202A1 Methods for reducing hyperacute rejection of xenografts
12/21/1995WO1995034201A1 pp60PIK: A DOWNSTREAM ELEMENT IN INSULIN SIGNALING
12/21/1995WO1995030761A3 Methods of in vivo gene delivery
12/21/1995WO1995030750A3 Lag-3 protein soluble polypeptide fractions, method of production, therapeutic composition and anti-idiotype antibody
12/21/1995WO1995029245A3 Btf2 complex proteins and uses thereof
12/21/1995WO1995027512A3 Compositions and methods for gene therapy to treat disease
12/21/1995WO1995027066A3 Dna encoding ubiquitin conjugating enzymes
12/21/1995WO1995020660A3 Immunization by inoculation of dna transcription unit
12/21/1995CA2225499A1 Epil/placentine
12/21/1995CA2193072A1 Corticotropin-releasing factor2 receptors
12/21/1995CA2193060A1 Inhibition of human xenogenic or allogenic antibodies to reduce xenograft or allograft rejection in human recipients
12/21/1995CA2192844A1 Fas associated proteins
12/21/1995CA2192661A1 Compositions for neutralization of lipopolysaccharides
12/21/1995CA2192660A1 Methods for reducing hyperacute rejection of xenografts
12/21/1995CA2192593A1 Suppression of tumor cell growth by syndecan-1 ectodomain
12/21/1995CA2192486A1 Pp60pik: a downstream element in insulin signaling
12/21/1995CA2192066A1 The production of hemoglobin having a .delta.-like globin
12/21/1995CA2191870A1 Cross-reacting monoclonal antibodies specific for e-selectin and p-selectin
12/21/1995CA2191845A1 Retroviral gene therapy vectors and therapeutic methods based thereon
12/21/1995CA2191733A1 Methods for inhibiting antigen specific t cell responses
12/21/1995CA2191479A1 Constrained peptides
12/21/1995CA2191065A1 Compositions and methods for the treatment of tumors
12/21/1995CA2169762A1 Immune modulation with class ii alpha-chain fragments
12/20/1995EP0687911A2 Methods for assaying endotoxin concentration
12/20/1995EP0687731A1 Secretion vector, transformed microorganisms containing said vector and manufacture of products from said microorganism
12/20/1995EP0687687A2 Pharmaceutical compositions for prevention and treatment of blood coagulation disorders
12/20/1995EP0687686A1 Aureobasidins
12/20/1995EP0687685A1 Physiologically active peptide
12/20/1995EP0687681A1 Immunogens for the production of cocaine-hydrolyzing catalytic antibodies
12/20/1995EP0687470A2 Agents for treating metabolic bone diseases
12/20/1995EP0687463A1 Hemoglobin-encapsulated liposome
12/20/1995EP0687300A1 LO-CD2a ANTIBODY AND USES THEREOF FOR INHIBITING T-CELL ACTIVATION AND PROLIFERATION
12/20/1995EP0687296A1 Variants of bile salt-stimulated lipase, dna molecules encoding them, and transgenic non-human mammals
12/20/1995EP0687295A1 Human b-lymphoblastoid cell line secreting anti-ganglioside antibody
12/20/1995EP0687273A1 Collagenase activity inhibitor and cosmetic composition containing same
12/20/1995EP0687270A1 Osteogenic growth oligopeptides and pharmaceutical compositions containing them
12/20/1995EP0687261A1 Acid cleavable compounds, their preparation and use as bifunctional acid-labile crosslinking agents
12/20/1995EP0687254A1 4-aminopyridines, their preparation and their use as antithrombotic agent
12/20/1995EP0687183A1 Synergistic composition of cd4-based protein and anti-hiv-1 antibody, and methods of using same
12/20/1995EP0687182A1 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus
12/20/1995EP0687181A1 Method of treating hepatitis c in non-responders to interferon treatment
12/20/1995EP0687180A1 Methods for detection and treatment of individuals having abnormal cells expressing hla-a2/tyrosinase peptide antigens
12/20/1995EP0645997B1 Cosmetic containing phospholipids and fluorocarbon compounds
12/20/1995EP0502036B1 Latency associated peptide and uses therefor
12/20/1995EP0394424B1 Peptides and polypeptides from the sub-maxilary gland of the rat, corresponding monoclonal and polyclonal antibodies, corresponding hybridomas and applications of said products to the diagnosis, detection or for therapeutical purposes
12/20/1995EP0375767B1 Peptides with protective properties with regard to a pathogenic virus of the hiv type in sensitive cells
12/20/1995CN1113518A A novel peptide related to human programmed cell death and DNA encoding it
12/20/1995CN1113517A 转录因子aprf Transcription factor aprf
12/20/1995CN1113493A Boron containing derivative and preparation and medical application of same
12/19/1995US5476922 Methods and compositions for the preparation and use of autocrine growth factors
12/19/1995US5476849 Methods for glycosylation inhibition using amino-benzoic acids and derivatives
12/19/1995US5476841 Peptide
12/19/1995US5476840 Hypotensive agents
12/19/1995US5476839 Variable N-terminal sequences; useful in the diagnosis and treatment of disease
12/19/1995US5476784 Medical diagnosis
12/19/1995US5476782 DNA encoding a human 5-HT1E receptor and uses thereof
12/19/1995US5476778 Method of growing and attenuating a viral agent associated with mystery swine disease
12/19/1995US5476777 Methods for producing thrombin
12/19/1995US5476666 Glycosaminoglycan-synthetic polymer conjugates
12/19/1995US5476663 Particles containing water soluble drug dispersed in spherical microcapsule matrix composed of copolymer of lactic acid and glycolic acid, excipient; for injection
12/19/1995US5476657 Pasteurella haemolytica leukotoxin compositions and uses thereof
12/19/1995US5476653 Polyoxymethylene-oxyethylene copolymers in conjuction with biomolecules
12/19/1995CA1337782C Polypeptide from horseshoe crab exhibiting affinity for lipopolysaccharide and method of preparation
12/19/1995CA1337781C Polypeptide from horseshoe crab exhibiting affinity for lipopolysaccharide and method of preparation
12/19/1995CA1337759C Glycopeptide antibiotic
12/19/1995CA1337758C Peptide antibiotics
12/19/1995CA1337756C Means and method for preventing and treating graft failure in humans
12/18/1995CA2152023A1 Agents for treating metabolic bone diseases
12/15/1995CA2150994A1 P53as protein and antibody therefor
12/14/1995WO1995033997A1 Alpha b crystallin for use in diagnosis and therapy of auto-immune diseases in particular multiple sclerosis
12/14/1995WO1995033856A1 Methods for detecting mutations associated with hypertrophic cardiomyopathy
12/14/1995WO1995033842A1 Safe retroviral vectors, their production and use
12/14/1995WO1995033841A1 Locus control subregions for integration-site independent transgene expression
12/14/1995WO1995033840A1 Recombinant viruses, preparation and use thereof in gene therapy
12/14/1995WO1995033834A1 Lag1: a gene for increasing the longevity of eukaryotes
12/14/1995WO1995033830A1 Bmp-9 compositions
12/14/1995WO1995033829A1 Pantropic neurotrophic factors
12/14/1995WO1995033828A1 Modified cells and methods for inhibiting hyperacute rejection of xenogeneic transplants
12/14/1995WO1995033819A2 Cdk4 (cyclin dependent kinase 4) binding proteins
12/14/1995WO1995033772A1 Flt4 receptor tyrosine kinase and its use in diagnosis and therapy
12/14/1995WO1995033771A1 MONOCLONAL ANTIBODY ACTIVE AGAINST CD44v6
12/14/1995WO1995033770A1 Ligands for induction of antigen specific apoptosis in t cells
12/14/1995WO1995033769A1 Process and intermediate products for preparing cardiodilatin fragments, and highly purified cardiodilatin fragments
12/14/1995WO1995033768A1 Aids prophylactics
12/14/1995WO1995033767A1 Helicobacter pylori nickel binding protein
12/14/1995WO1995033766A1 Branched synthetic peptide conjugate
12/14/1995WO1995033765A1 Conformationally constrained backbone cyclized peptide analog
12/14/1995WO1995033763A1 Novel elastase inhibitors
12/14/1995WO1995033762A1 Perfluoroalkyl ketone inhibitors of elastase and processes for making the same
12/14/1995WO1995033759A2 Antisense oligonucleotides and methods for the treatment of schistosomiasis
12/14/1995WO1995033751A1 Bicycling lactam inhibitor of interleukin-1-beta converting enzyme
12/14/1995WO1995033499A1 Isolated dna encoding c-mer protooncogene
1 ... 2812 2813 2814 2815 2816 2817 2818 2819 2820 2821 2822 2823 2824 2825 2826 2827 2828 2829 2830 2831 2832 ... 3163